Organogenesis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Organogenesis and other ETFs, options, and stocks.About ORGO
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
CEOGary S. Gillheeney
CEOGary S. Gillheeney
Employees869
Employees869
HeadquartersCanton, Massachusetts
HeadquartersCanton, Massachusetts
Founded1985
Founded1985
Employees869
Employees869
ORGO Key Statistics
Market cap473.38M
Market cap473.38M
Price-Earnings ratio-37.82
Price-Earnings ratio-37.82
Dividend yield—
Dividend yield—
Average volume596.86K
Average volume596.86K
High today$4.10
High today$4.10
Low today$3.70
Low today$3.70
Open price$3.85
Open price$3.85
Volume817.42K
Volume817.42K
52 Week high$7.08
52 Week high$7.08
52 Week low$2.61
52 Week low$2.61
Stock Snapshot
As of today, Organogenesis(ORGO) shares are valued at $3.86. The company's market cap stands at 473.38M, with a P/E ratio of -37.82.
During the trading session on 2026-02-06, Organogenesis(ORGO) shares reached a daily high of $4.10 and a low of $3.70. At a current price of $3.86, the stock is +4.5% higher than the low and still -5.9% under the high.
Trading activity shows a volume of 817.42K, compared to an average daily volume of 596.86K.
The stock's 52-week range extends from a low of $2.61 to a high of $7.08.
The stock's 52-week range extends from a low of $2.61 to a high of $7.08.
People also own
Based on the portfolios of people who own ORGO. This list is generated using Robinhood data, and it’s not a recommendation.